UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (date of earliest event reported): June 9, 2014
SYNERGETICS USA, INC.
(Exact name of registrant as specified in its charter)
|
Delaware
|
001-10382
|
20-5715943
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
|
3845 Corporate Centre Drive
|
|
|
|
O’Fallon, Missouri
|
|
63368
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
(636) 939-5100
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| |
o
|
Written communications pursuant to Rule 425 under the Securities Act.
|
| |
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act.
|
| |
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
|
| |
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
|
| Item 2.02. |
Results of Operations and Financial Condition. |
On June 9, 2014, Synergetics USA, Inc. (the “Company”) issued a press release announcing its financial results for the third fiscal quarter ended April 30, 2014. A copy of this press release is attached hereto as Exhibit 99.1 and incorporated herein by reference. The information contained in the website is not a part of this Current Report on Form 8-K.
The information under this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Also on June 9, 2014, the Company issued a press release announcing the introduction of the Company’s VersaVIT 2.0TM vitrectomy system. A copy of this press release is filed hereto as Exhibit 99.2 and incorporated herein by reference. The information contained in the website is not a part of this Current Report on Form 8-K.
|
Item 9.01.
|
Financial Statements and Exhibits.
|
(d) Exhibits.
|
Exhibit No.
|
|
Description of Exhibit
|
|
|
|
Press release of Synergetics USA, Inc. dated June 9, 2014 announcing financial results for the quarter ended April 30, 2014.
|
| |
|
|
|
|
|
Press release of Synergetics USA, Inc. dated June 9, 2014 announcing the introduction of the VersaVIT 2.0TM vitrectomy system.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: June 9, 2014
|
SYNERGETICS USA, INC.
(Registrant)
|
|
|
|
|
|
|
By:
|
/s/ Pamela G. Boone
|
|
|
Name:
|
Pamela G. Boone
|
|
|
Title:
|
EVP and Chief Financial Officer
|
|